Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation

Stem Cell Therapy for Ischemic Cardiomyopathy

Presenter: Muzammil Mushtaq

October 31, 2015

Presentation TCT 2015

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

Presenter: Andrea Abizaid, Daniel Burkhoff, Salvatore Brugaletta

October 14, 2015

Presentation TCT 2015

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Presenter: David P. Faxon, David O. Williams, Martin W Bergmann

October 13, 2015

Presentation

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy

Presenter: E.C. Perin

April 21, 2014

Presentation TVT 2013

Impact of Function MR on Outcomes in Ischemic and Idiopathic Dilated Cardiomyopathy: Major Culprit or Innocent Bystander?

Presenter: Maurice Sarano

June 14, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

Presentation TCT 2012

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Presenter: Martyn Thomas

October 23, 2012

Presentation TCT 2012

Functional MR Due to Idiopathic vs. Ischemic Cardiomyopathy (and Due to Anterior vs. Posterior Infarction): Similarities and Differences

Presenter: Blase Carabello

October 23, 2012

Presentation TCT 2012

Impact of the Different Route of Cell Delivery in Chronic Ischemic Cardiomyopathy Ovine Model

Presenter: Yanping Cheng, Geng-Hua Yi, Armando Tellez, Greg L. Kaluza, Juan F. Granada

January 03, 2012

Advertisement

Stem Cell Therapy for Ischemic Cardiomyopathy

Initial Clinical Results of Transcatheter Technique for LV Volume Reduction Treatment of Ischemic Cardiomyopathy

ALSTER-CERA: Evaluation of NOGA-Guided Intramyocardial Injection of a Long-Acting Erythropoietin Analogue in Patients With Ischemic Cardiomyopathy

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy

Impact of Function MR on Outcomes in Ischemic and Idiopathic Dilated Cardiomyopathy: Major Culprit or Innocent Bystander?

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

First Report of a Confirmatory (Cohort B) Study of the Parachute Device in Ischemic Dilated Cardiomyopathy

Functional MR Due to Idiopathic vs. Ischemic Cardiomyopathy (and Due to Anterior vs. Posterior Infarction): Similarities and Differences

Impact of the Different Route of Cell Delivery in Chronic Ischemic Cardiomyopathy Ovine Model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content